These results indicate that the levels of the GGT isoenzyme GGTII also increased in the early stage of liver cancer, but the increase was not significant compared with that in the N-PLC group (LC group and CHB group), which is inconsistent with the results of some domestic and foreign studies. This evidence concerns the gene HSPG2 and laryngotracheoesophageal cleft.